Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001367644-25-000036
Filing Date
2025-03-04
Accepted
2025-03-04 17:07:33
Documents
14

Document Format Files

Seq Description Document Type Size
1 424B3 ebs-424b3.htm 424B3 2741882
2 a1.jpg GRAPHIC 17905
3 a2.jpg GRAPHIC 6516
4 a3.jpg GRAPHIC 5647
5 a4.jpg GRAPHIC 1828
6 a5.jpg GRAPHIC 1288
7 anthrasillogo.jpg GRAPHIC 4884
8 anthrasillogo_multicolorli.jpg GRAPHIC 2468
9 chart-0c4168ed82f44f9db98.jpg GRAPHIC 103519
10 emergentlogograycarminer.jpg GRAPHIC 75656
11 grayasterisk1.jpg GRAPHIC 4779
12 grayasterisk2.jpg GRAPHIC 6258
13 redasterisk.jpg GRAPHIC 3481
14 written.jpg GRAPHIC 18295
  Complete submission text file 0001367644-25-000036.txt   3091886
Mailing Address 300 PROFESSIONAL DR GAITHERSBURG MD 20879
Business Address 300 PROFESSIONAL DR GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

EIN.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-283150 | Film No.: 25706097
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)